Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab

Conditions: Multiple Sclerosis; Tomography, Optical Coherence; Retinal Degeneration; Visual Acuity Interventions: Drug: Ofatumumab Sponsors: Johns Hopkins University; Novartis Enrolling by invitation

https://clinicaltrials.gov/study/NCT06167642

Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials